Experts are developing innovative ways to deal with mask shortages and lay the groundwork for better options going forward.
here’s promising first data on the effectiveness of the experimental drug remdesivir to treat Covid-19. Published Friday, April 10 in the New England Journal of Medicine, 36 out of 53 patients (68%) who received the drug showed signs of improvement, 25 of whom were eventually sent home. Seven people (13%) died. Of the 30 people who were on ventilators in the study, 57% were able to come off oxygen support.
A daily Covid-19 update from Andy Slavitt, former head of the Centers for Medicare and Medicaid Services
Highly cost effective: MHC is operating at no profit during the Covid-19 crisis with low costs through associate practitioners and online model.